Payal Kohli, MD

March 02, 2015

A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).

February 27, 2015

What is your command of the components of this risk prediction tool for patients with atrial fibrillation? Find out with our 4-question quiz.

February 06, 2015

The absence of an antidote may soon disappear as a reason to avoid prescribing a novel oral anticoagulant to patients with atrial fibrillation, based on promising phase III trial results.

February 06, 2015

When is a rhythm control strategy appropriate? Which patients are candidates for amiodarone? When is AF ablation the answer? Here, a top-line review of rhythm control for atrial fibrillation.

December 12, 2014

The risk for major bleeding and GI hemorrhage in patients taking dabigatran was greater than in those taking warfarin; warfarin, however, was associated with a greater risk of intracranial hemorrhage.

December 11, 2014

In analysis of this randomized controlled trial of apixaban vs warfarin for nonvalvular atrial fibrillation, there was an increased risk of stroke and systemic embolism among patients taking amiodarone and warfarin.

November 08, 2014

Overall it looks as though pharmacologic rate control is still the preferred therapy for new onset AF, but a new study identifies some interesting trends in the use of drugs for both rhythm and rate.

November 08, 2014

Atrial fibrillation and dementia have long been linked, partly because both tend to affect the elderly. But there may be a causal link as well related to management of anticoagulation.

November 08, 2014

The recent AFFORD trial suggests no clinical role for omega-3 fatty acids in preventing atrial fibrillation or in modulating disease markers.

October 14, 2014

A new study finds that iPhone-based technology deployed in local pharmacies can detect asymptomatic atrial fibrillation. iECG anyone?